EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

CD300e is a driver of the immunosuppressive tumor microenvironment and colorectal cancer progression via macrophage reprogramming

Annica Barizza, Stefania Vassallo, Laura Masatti, Mattia Laffranchi, Sofia Giacometti, Silvia Lonardi, Mattia Bugatti, Sara Coletta, Chiara Della Bella, Mario Milco D'Elios, Simone Pizzini, Antonio Rosato und 7 weitere

Journal for ImmunoTherapy of Cancer · 2025

DOI: 10.1136/jitc-2025-013249 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal for ImmunoTherapy of Cancer, 2025. Verfasst von Annica Barizza und 18 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biology, University of Padua, Padua, Italy. Hauptthemen laut MEDLINE: Colorectal Neoplasms, Tumor Microenvironment, Receptors, Immunologic, Macrophages. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Associazione Italiana per la Ricerca sul Cancro.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Colorectal cancer (CRC) progression is shaped by the tumor microenvironment, particularly tumor-associated macrophages (TAMs), which often adopt immunosuppressive functions. CD300e, a myeloid receptor involved in immune regulation, has an uncharacterized role in CRC.

Methods

Functional studies were conducted in azoxymethane/dextran sodium sulfate and MC38 murine CRC models using CD300e systemic and myeloid-specific CD300e knockout mice, and adoptive transfer experiments assessed macrophage-intrinsic effects. Human studies included analysis of CD300e expression in matched tumor and normal tissue from patients with CRC and in vitro co-culture of patient-derived colon tumor organoids with monocytes to study CD300e induction and TAM polarization.

Results

In vivo, CD300e deficiency led to reduced tumor burden, enhanced major histocompatibility complex expression on TAMs, and improved T-cell responses. CD300e-deficient macrophages exhibited increased phagocytic activity, antigen presentation, and support for T-cell proliferation and cytotoxicity. Adoptive transfer confirmed that macrophage-intrinsic CD300e expression is sufficient to suppress T-cell function and promote tumor growth. In patients with CRC, CD300e is selectively upregulated in tumor-infiltrating monocytes and macrophages, driving a suppressive phenotype marked by impaired antigen presentation. Tumor-derived signals in vitro induce CD300e expression and promote a protumorigenic macrophage profile.

Conclusions

Our findings identify CD300e as a critical regulator of macrophage-mediated immune suppression in CRC and a potential target for reprogramming TAMs to enhance immunotherapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Colorectal NeoplasmsTumor MicroenvironmentReceptors, ImmunologicMacrophagesTumor-Associated MacrophagesAnimalsMiceHumansDisease ProgressionMice, KnockoutCellular ReprogrammingFemaleDisease Models, Animal

Stichwörter der Autor:innen

Colorectal CancerImmune modulatoryMacrophageTumor microenvironment - TME

Substanzen

Receptors, Immunologic

Autor:innen und Institutionen

  • Department of Biology, University of Padua, Padua, Italy.
  • Molecular Medicine, University of Rome La Sapienza, Rome, Italy.
  • Section of Pathology, University of Brescia, Brescia, Italy.
  • Molecular and Developmental Medicine, University of Siena, Siena, Italy.
  • Department of Surgery, Oncology and Gastroenterology, Immunology and Oncology Section, University of Padua, Padova, Italy.
  • Veneto Institute of Oncology IOV - IRCCS, Veneto Oncology Institute, Padua, Italy.

Förderung

  • Associazione Italiana per la Ricerca sul Cancro

Zitieren

APA

Barizza, A., Vassallo, S., Masatti, L., Laffranchi, M., Giacometti, S., Lonardi, S., Bugatti, M., Coletta, S., Della Bella, C., D'Elios, M. M., Pizzini, S., Rosato, A., Vermi, W., Fassan, M., Spolverato, G., Sozzani, S., Calura, E., Sommaggio, R., & Codolo, G. (2025). CD300e is a driver of the immunosuppressive tumor microenvironment and colorectal cancer progression via macrophage reprogramming. Journal for ImmunoTherapy of Cancer. https://doi.org/10.1136/jitc-2025-013249

Vancouver

Barizza A, Vassallo S, Masatti L, Laffranchi M, Giacometti S, Lonardi S, et al. CD300e is a driver of the immunosuppressive tumor microenvironment and colorectal cancer progression via macrophage reprogramming. Journal for ImmunoTherapy of Cancer. 2025. doi:10.1136/jitc-2025-013249

BibTeX
@article{Barizza2025,
  author = {Barizza, Annica and Vassallo, Stefania and Masatti, Laura and Laffranchi, Mattia and Giacometti, Sofia and Lonardi, Silvia and Bugatti, Mattia and Coletta, Sara and Della Bella, Chiara and D'Elios, Mario Milco and Pizzini, Simone and Rosato, Antonio and Vermi, William and Fassan, Matteo and Spolverato, Gaya and Sozzani, Silvano and Calura, Enrica and Sommaggio, Roberta and Codolo, Gaia},
  title = {CD300e is a driver of the immunosuppressive tumor microenvironment and colorectal cancer progression via macrophage reprogramming},
  journal = {Journal for ImmunoTherapy of Cancer},
  year = {2025},
  doi = {10.1136/jitc-2025-013249}
}
Kostenlos starten →